Trump demands drug price cuts within 60 days, causing pharma market turmoil
President Trump has increased pressure on major pharmaceutical companies to lower U.S. drug prices to match those paid in other wealthy countries, sending letters to 17 firms with a deadline of September 29. The administration seeks to enforce lower prices through various measures, though details on enforcement are vague. Industry groups oppose these demands, citing potential harm to innovation and market competition. Some companies are already exploring direct-to-consumer sales models as a response.
